SHA68Intervention1 paperPubChemHumans1LatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 monthsCancer Immunology Research·24 AprNMB+CXCL13+CD4+ T Cell-Derived Neuromedin B Promotes Neuropeptide S Receptor 1-Positive Malignant Cell Senescence and MalignancyStudy in peopleCellular senescencePaper
Cancer Immunology Research·24 AprNMB+CXCL13+CD4+ T Cell-Derived Neuromedin B Promotes Neuropeptide S Receptor 1-Positive Malignant Cell Senescence and MalignancyStudy in peopleCellular senescencePaper